Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 548

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27

Mamounas, Eleftherios P., Brown, Ann, Anderson, Stewart, Smith, Roy, Julian, Thomas, Miller, Barbara, Bear, Harry D., Caldwell, Christopher B., Walker, Alonzo P., Mikkelson, Wendy M., Stauffer, Jay S., Robidoux, Andre, Theoret, Heather, Sovan, Atilla, Fisher, Bernard, Wickerham, D. Lawrence, Wolmark, Norman·2005·Journal of Clinical Oncology

Abstract

Purpose: Experience with sentinel node biopsy (SNB) after neoadjuvant chemotherapy is limited. We examined the feasibility and accuracy of this procedure within a randomized trial in patients treated with neoadjuvant chemotherapy. Patients and Methods: During the conduct of National Surgical Adjuvant Breast and Bowel Project trial B-27, several participating surgeons attempted SNB before the required axillary dissection in 428 patients. All underwent lymphatic mapping and an attempt to identify and remove a sentinel node. Lymphatic mapping was performed with radioactive colloid (14.7%), with lymphazurin blue dye alone (29.9%), or with both (54.7%). Results: Success rate for the identification and removal of a sentinel node was 84.8%. Success rate increased significantly with the use of radioisotope (87.6% to 88.9%) versus with the use of lymphazurin alone (78.1%, P = .03). There were no significant differences in success rate according to clinical tumor size, clinical nodal status, age, or calendar year of random assignment. Of 343 patients who had SNB and axillary dissection, the sentinel nodes were positive in 125 patients and were the only positive nodes in 70 patients (56.0%). Of the 218 patients with negative sentinel nodes, nonsentinel nodes were positive in 15 (false-negative rate, 10.7%; 15 of 140 patients). There were no significant differences in false-negative rate according to clinical patient and tumor characteristics, method of lymphatic mapping, or breast tumor response to chemotherapy. Conclusion: These results are comparable to those obtained from multicenter studies evaluating SNB before systemic therapy and suggest that the sentinel node concept is applicable following neoadjuvant chemotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2005.05.188

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 548

Metadata

Authors
Mamounas, E. P., Brown, A., Anderson, S., Smith, R., Julian, T., Miller, B., Bear, H. D., Caldwell, C. B., Walker, A. P., Mikkelson, W. M., Stauffer, J. S., Robidoux, A., Theoret, H., Sovan, A., Fisher, B., Wickerham, D. L., & Wolmark, N.
Venue
Journal of Clinical Oncology
Published
2005-04-20
Volume
23
Issue
12
Pages
2694-2702
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2147077806
Cited by
548
References
12
FWCI
9.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27. https://app.cochat.ai/papers/10.1200/jco.2005.05.188
The paper
Mamounas, E. P., Brown, A., Anderson, S., Smith, R., Julian, T., Miller, B., Bear, H. D., Caldwell, C. B., Walker, A. P., Mikkelson, W. M., Stauffer, J. S., Robidoux, A., Theoret, H., Sovan, A., Fisher, B., Wickerham, D. L., & Wolmark, N. (2005). Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2005.05.188

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.